The University of Chicago Header Logo

Kathleen Mullane

Concepts (346)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
14
2019
788
2.830
Why?
Vancomycin
10
2016
73
2.420
Why?
Clostridium Infections
10
2022
124
2.390
Why?
Hematopoietic Stem Cell Transplantation
16
2023
890
2.010
Why?
Antifungal Agents
13
2020
120
1.960
Why?
Enterocolitis, Pseudomembranous
8
2019
52
1.940
Why?
Herpes Zoster
5
2019
79
1.870
Why?
Triazoles
10
2018
102
1.690
Why?
Aminoglycosides
7
2013
32
1.640
Why?
Herpes Zoster Vaccine
3
2019
10
1.280
Why?
Invasive Fungal Infections
5
2020
10
1.280
Why?
Antiviral Agents
10
2021
478
1.240
Why?
Nitriles
5
2018
160
1.060
Why?
Immunocompromised Host
12
2021
142
1.050
Why?
Pyridines
6
2018
315
1.020
Why?
Organophosphonates
3
2018
50
0.820
Why?
Cytosine
3
2018
128
0.770
Why?
Organ Transplantation
3
2019
276
0.720
Why?
Double-Blind Method
15
2023
1719
0.710
Why?
Cytomegalovirus Infections
5
2019
148
0.650
Why?
Mycoses
3
2020
46
0.610
Why?
Peptides, Cyclic
2
2016
44
0.610
Why?
Thiazoles
2
2014
128
0.580
Why?
Adenosine Monophosphate
3
2021
27
0.560
Why?
Lipopeptides
2
2016
17
0.560
Why?
Alanine
3
2021
83
0.550
Why?
Valine
1
2016
62
0.550
Why?
Herpesvirus 3, Human
1
2016
41
0.550
Why?
Adult
43
2022
26607
0.540
Why?
Drugs, Investigational
1
2016
39
0.540
Why?
Acyclovir
1
2016
108
0.540
Why?
Middle Aged
40
2024
25974
0.530
Why?
Aged
29
2020
19165
0.510
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
173
0.500
Why?
Transplant Recipients
6
2023
137
0.480
Why?
Male
51
2024
42411
0.470
Why?
Humans
68
2024
89357
0.450
Why?
Invasive Pulmonary Aspergillosis
3
2018
8
0.440
Why?
Daptomycin
1
2013
3
0.440
Why?
Minocycline
1
2013
15
0.440
Why?
Treatment Outcome
21
2020
8241
0.440
Why?
Edetic Acid
1
2013
42
0.430
Why?
Biofilms
1
2013
46
0.420
Why?
Female
42
2020
46202
0.420
Why?
Practice Guidelines as Topic
1
2019
1047
0.400
Why?
Methicillin-Resistant Staphylococcus aureus
1
2013
78
0.400
Why?
Actinomycetales
1
2011
5
0.390
Why?
Nucleic Acid Synthesis Inhibitors
1
2011
16
0.390
Why?
Neoplasms
2
2019
3041
0.380
Why?
Respiratory Syncytial Virus Infections
2
2020
24
0.370
Why?
Administration, Oral
6
2018
682
0.370
Why?
HIV Infections
4
2013
840
0.370
Why?
Ethanol
1
2013
250
0.360
Why?
Aged, 80 and over
10
2018
6811
0.350
Why?
Renal Insufficiency, Chronic
1
2013
219
0.350
Why?
Gastrointestinal Tract
1
2011
191
0.330
Why?
Respiratory Tract Infections
2
2020
106
0.330
Why?
Hematologic Neoplasms
3
2020
343
0.320
Why?
Administration, Intravenous
5
2020
57
0.310
Why?
Mucormycosis
4
2018
15
0.300
Why?
Young Adult
9
2018
6312
0.280
Why?
Randomized Controlled Trials as Topic
3
2018
838
0.270
Why?
Acetates
2
2017
65
0.270
Why?
Diarrhea
4
2015
182
0.260
Why?
Pneumonia, Viral
2
2020
319
0.250
Why?
Coronavirus Infections
2
2020
304
0.250
Why?
Adolescent
13
2018
9263
0.250
Why?
Legionellosis
1
2024
6
0.240
Why?
Legionella
1
2024
16
0.240
Why?
Quinazolines
2
2017
221
0.240
Why?
Vaccination
2
2019
274
0.240
Why?
Severe Acute Respiratory Syndrome
1
2003
8
0.230
Why?
Transplantation, Homologous
4
2016
996
0.220
Why?
Pneumococcal Infections
1
2023
47
0.220
Why?
Cytomegalovirus
3
2018
78
0.220
Why?
Vaccines, Inactivated
2
2019
29
0.210
Why?
Clinical Trials, Phase III as Topic
2
2013
175
0.200
Why?
Drug-Related Side Effects and Adverse Reactions
3
2018
203
0.200
Why?
Mycobacterium chelonae
1
2021
4
0.190
Why?
DNA, Viral
3
2017
262
0.190
Why?
Reaction Time
2
1999
310
0.190
Why?
Mycobacterium Infections, Nontuberculous
1
2021
27
0.190
Why?
Coronary Disease
2
1995
260
0.180
Why?
Agammaglobulinemia
1
2020
20
0.180
Why?
Betacoronavirus
2
2020
261
0.180
Why?
Drug Resistance, Viral
2
2019
48
0.180
Why?
Cardiomyopathies
2
2017
264
0.180
Why?
Anti-HIV Agents
2
1999
159
0.180
Why?
Fecal Microbiota Transplantation
2
2022
64
0.170
Why?
Injection Site Reaction
1
2019
2
0.170
Why?
Kaplan-Meier Estimate
4
2017
860
0.170
Why?
Severity of Illness Index
3
2017
1840
0.170
Why?
Recurrence
3
2017
1144
0.160
Why?
Bordetella Infections
1
2018
5
0.160
Why?
Aminoimidazole Carboxamide
2
1995
7
0.160
Why?
Drug Therapy, Combination
5
2011
784
0.160
Why?
Ribonucleosides
2
1995
25
0.160
Why?
Bacterial Infections
1
2020
184
0.160
Why?
Mycobacterium tuberculosis
1
2021
195
0.160
Why?
Neutrophils
4
1999
308
0.150
Why?
Psychomotor Performance
3
2000
496
0.150
Why?
Coinfection
1
2018
61
0.150
Why?
Diagnostic Errors
1
2018
160
0.150
Why?
Renal Insufficiency
1
2018
98
0.150
Why?
Chemoprevention
1
2017
92
0.150
Why?
Neutropenia
1
2018
216
0.140
Why?
Herpesvirus 6, Human
1
2017
19
0.140
Why?
Survival Analysis
2
2018
1534
0.140
Why?
Investigational New Drug Application
1
2016
2
0.140
Why?
Disease Management
1
2019
329
0.140
Why?
Microbial Sensitivity Tests
3
2012
150
0.140
Why?
Foscarnet
1
2016
12
0.140
Why?
Zygomycosis
2
2007
3
0.140
Why?
Myocarditis
1
2017
51
0.140
Why?
Antineoplastic Agents
2
2019
2415
0.140
Why?
Hepatitis B virus
1
2016
44
0.140
Why?
Infectious Disease Transmission, Vertical
1
2016
46
0.140
Why?
Health Behavior
1
2017
185
0.130
Why?
Hepatitis B
1
2016
76
0.130
Why?
Antibiotic Prophylaxis
1
2016
77
0.130
Why?
Mannans
1
2015
5
0.130
Why?
beta-Glucans
1
2015
5
0.130
Why?
Pregnancy Complications, Infectious
1
2016
117
0.130
Why?
Societies, Medical
1
2019
575
0.130
Why?
Cognition
1
1999
580
0.120
Why?
Candida
2
2012
18
0.120
Why?
Graft vs Host Disease
1
2016
360
0.120
Why?
Opportunistic Infections
1
2014
60
0.110
Why?
Tissue Plasminogen Activator
1
1995
171
0.110
Why?
Multivariate Analysis
2
2013
988
0.110
Why?
Vaccines, Attenuated
1
2013
51
0.110
Why?
Fibrinolytic Agents
1
1995
217
0.110
Why?
Histoplasmosis
1
2013
26
0.110
Why?
Aspergillus
3
2018
9
0.110
Why?
Clinical Medicine
1
2013
34
0.110
Why?
Clinical Laboratory Techniques
1
2013
76
0.110
Why?
Drug Combinations
1
2013
203
0.100
Why?
Amphotericin B
2
2009
34
0.100
Why?
Enterococcus
1
2012
35
0.100
Why?
Prospective Studies
6
2015
4289
0.100
Why?
HIV-1
3
1998
166
0.100
Why?
Drug Administration Schedule
3
2020
895
0.100
Why?
DNA-Directed RNA Polymerases
1
2011
103
0.090
Why?
Microbiota
1
2015
402
0.090
Why?
Cross Infection
1
2011
147
0.090
Why?
Mucor
1
2009
3
0.090
Why?
Fungi
3
2018
66
0.090
Why?
Retrospective Studies
2
2021
9057
0.080
Why?
Thromboxane-A Synthase
1
1989
4
0.080
Why?
Multiple Myeloma
2
2018
330
0.080
Why?
Glycosides
1
2008
20
0.080
Why?
Angiotensin-Converting Enzyme Inhibitors
1
1989
91
0.080
Why?
Myocardial Reperfusion Injury
1
1989
58
0.080
Why?
Gastrointestinal Diseases
1
2009
151
0.080
Why?
Arachidonic Acids
1
1988
41
0.070
Why?
Substance-Related Disorders
2
2003
415
0.070
Why?
Acquired Immunodeficiency Syndrome
2
1999
81
0.070
Why?
AIDS Dementia Complex
2
1998
8
0.070
Why?
Aspergillosis
2
2018
41
0.070
Why?
Feces
3
2014
330
0.070
Why?
Leukemia, Myeloid, Acute
2
2017
793
0.070
Why?
Treatment Failure
2
2019
287
0.070
Why?
Salvage Therapy
1
2007
236
0.070
Why?
Fungemia
1
2005
15
0.060
Why?
Child
6
2022
7174
0.060
Why?
Candidiasis
1
2005
37
0.060
Why?
United States
4
2022
6989
0.060
Why?
Bacterial Proteins
1
2011
892
0.060
Why?
Lipoproteins
1
2005
136
0.060
Why?
CD4 Lymphocyte Count
3
1999
67
0.060
Why?
Incidence
3
2014
1595
0.060
Why?
Endocarditis, Bacterial
1
2024
39
0.060
Why?
Urokinase-Type Plasminogen Activator
1
2004
51
0.060
Why?
Hospitalization
2
2020
877
0.060
Why?
Pandemics
2
2020
773
0.060
Why?
Pyrimidines
1
2007
374
0.060
Why?
Graft Occlusion, Vascular
1
2004
99
0.060
Why?
Dose-Response Relationship, Drug
3
2014
1942
0.060
Why?
Vaccines, Conjugate
1
2023
6
0.060
Why?
Fatal Outcome
1
2024
299
0.060
Why?
Immunogenicity, Vaccine
1
2023
13
0.060
Why?
Catheters, Indwelling
1
2004
113
0.060
Why?
Pneumococcal Vaccines
1
2023
28
0.060
Why?
Voriconazole
2
2018
18
0.060
Why?
Patient Isolation
1
2003
14
0.060
Why?
Catheterization, Central Venous
1
2004
115
0.060
Why?
Disaster Planning
1
2003
24
0.060
Why?
Antibodies, Bacterial
1
2023
100
0.050
Why?
Zidovudine
2
1999
16
0.050
Why?
HIV Seropositivity
2
2000
51
0.050
Why?
Recombinant Proteins
3
2004
1012
0.050
Why?
Cell- and Tissue-Based Therapy
1
2022
51
0.050
Why?
Platelet Aggregation
2
1994
44
0.050
Why?
Leukoencephalopathy, Progressive Multifocal
1
2001
13
0.050
Why?
Immunoglobulin G
1
2023
465
0.050
Why?
AIDS-Related Opportunistic Infections
1
2001
33
0.050
Why?
Secondary Prevention
2
2013
158
0.050
Why?
Granulocyte Colony-Stimulating Factor
2
1999
166
0.050
Why?
Child, Preschool
4
2013
3731
0.050
Why?
Antiretroviral Therapy, Highly Active
1
2001
73
0.050
Why?
Patient Acuity
1
2020
33
0.050
Why?
Verbal Learning
1
2000
29
0.050
Why?
Lung Transplantation
1
2024
292
0.050
Why?
Respiratory System
1
2020
116
0.040
Why?
Immunoglobulins, Intravenous
1
2020
65
0.040
Why?
Zalcitabine
1
1999
2
0.040
Why?
Didanosine
1
1999
2
0.040
Why?
CD4-CD8 Ratio
1
1999
18
0.040
Why?
Oxygen Inhalation Therapy
1
2020
60
0.040
Why?
Biomarkers
2
2016
1767
0.040
Why?
Bordetella bronchiseptica
1
2018
6
0.040
Why?
Statistics, Nonparametric
1
1999
306
0.040
Why?
Diagnosis, Differential
1
2003
1597
0.040
Why?
Bordetella pertussis
1
2018
15
0.040
Why?
Infant
3
2016
3160
0.040
Why?
Phagocytes
1
1998
11
0.040
Why?
Multiplex Polymerase Chain Reaction
1
2018
35
0.040
Why?
Cross Reactions
1
2018
109
0.040
Why?
Odds Ratio
1
2020
683
0.040
Why?
False Positive Reactions
1
2018
223
0.040
Why?
Mucorales
1
2018
2
0.040
Why?
Choice Behavior
1
1999
160
0.040
Why?
Reactive Oxygen Species
2
1998
490
0.040
Why?
Blood Platelets
2
1989
150
0.040
Why?
Rare Diseases
1
2018
70
0.040
Why?
DNA, Bacterial
1
2018
243
0.040
Why?
Psychiatric Status Rating Scales
1
1999
492
0.040
Why?
Allografts
1
2018
181
0.040
Why?
Dogs
2
1995
704
0.040
Why?
Terminology as Topic
1
2019
221
0.040
Why?
Biopsy
1
2021
1184
0.040
Why?
Memory Disorders
1
1997
69
0.040
Why?
Social Isolation
1
2017
67
0.040
Why?
Transplantation, Autologous
1
2018
344
0.040
Why?
Memory, Short-Term
1
2000
227
0.040
Why?
Hepatitis B e Antigens
1
2016
7
0.030
Why?
Pilot Projects
1
1999
871
0.030
Why?
Hepatitis B Surface Antigens
1
2016
23
0.030
Why?
Hepatitis B Antibodies
1
2016
16
0.030
Why?
Parturition
1
2016
21
0.030
Why?
Lymphoma
1
2018
265
0.030
Why?
Femoral Vein
1
2016
39
0.030
Why?
Prognosis
2
2015
3783
0.030
Why?
Immunization
1
2016
160
0.030
Why?
Fetal Blood
1
2016
93
0.030
Why?
Leukemia
1
2018
323
0.030
Why?
Risk Factors
2
2019
5499
0.030
Why?
Enema
1
2015
39
0.030
Why?
Registries
1
2020
784
0.030
Why?
Viral Load
1
2016
145
0.030
Why?
Infant, Newborn
2
2016
2486
0.030
Why?
Disease-Free Survival
1
2018
1214
0.030
Why?
Galactose
1
2015
32
0.030
Why?
Mothers
1
2016
142
0.030
Why?
Health Status
1
2017
371
0.030
Why?
5,8,11,14-Eicosatetraynoic Acid
1
1994
2
0.030
Why?
Placenta
1
2016
179
0.030
Why?
Case-Control Studies
1
1999
1862
0.030
Why?
Catalase
1
1994
49
0.030
Why?
Peroxidase
1
1994
51
0.030
Why?
Perfusion
1
1995
236
0.030
Why?
Survival Rate
1
2018
1901
0.030
Why?
Myelodysplastic Syndromes
1
2017
358
0.030
Why?
Mental Recall
1
1995
158
0.030
Why?
Animals
5
2016
27371
0.030
Why?
Cross-Sectional Studies
1
1999
1714
0.030
Why?
Attention
1
1998
395
0.030
Why?
Apoptosis
2
1999
1717
0.030
Why?
Luminescent Measurements
3
1999
62
0.030
Why?
Arachidonic Acid
2
1994
63
0.030
Why?
Free Radicals
2
1994
71
0.030
Why?
Limit of Detection
1
2012
20
0.030
Why?
Drug Resistance, Bacterial
1
2012
75
0.030
Why?
Canada
1
2012
208
0.020
Why?
Adenosine
1
1994
238
0.020
Why?
Polymerase Chain Reaction
1
2013
922
0.020
Why?
Intention to Treat Analysis
1
2011
69
0.020
Why?
Neuropsychological Tests
3
1998
505
0.020
Why?
Logistic Models
1
2013
1213
0.020
Why?
Surveys and Questionnaires
1
2017
2624
0.020
Why?
Phenylacetates
1
1989
3
0.020
Why?
Rats, Inbred SHR
1
1989
33
0.020
Why?
Hydralazine
1
1989
19
0.020
Why?
Respiratory Burst
2
1999
18
0.020
Why?
Magnetic Resonance Imaging
1
2001
3448
0.020
Why?
Indomethacin
1
1989
59
0.020
Why?
Pregnancy
1
2016
3018
0.020
Why?
Fatty Acids, Unsaturated
1
1989
28
0.020
Why?
Benzazepines
1
1989
64
0.020
Why?
Drug Synergism
1
1989
306
0.020
Why?
Eicosanoic Acids
1
1988
2
0.020
Why?
Lipoxygenase
1
1988
8
0.020
Why?
SRS-A
1
1988
27
0.020
Why?
Cell Communication
1
1989
199
0.020
Why?
Platelet Activating Factor
1
1988
53
0.020
Why?
Superoxides
1
1988
74
0.020
Why?
Serotonin
1
1988
221
0.020
Why?
Sulfonamides
1
1989
318
0.020
Why?
Echinocandins
1
2005
5
0.020
Why?
Internationality
1
2005
69
0.020
Why?
Blood Pressure
1
1989
900
0.020
Why?
Placebos
1
2004
214
0.010
Why?
Age Distribution
1
2004
200
0.010
Why?
Kidney
1
1989
1147
0.010
Why?
Oxygen
1
1988
743
0.010
Why?
Hemorrhage
1
2004
280
0.010
Why?
Rats
1
1989
4041
0.010
Why?
Kinetics
1
2004
1528
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2000
374
0.010
Why?
Filgrastim
1
1999
57
0.010
Why?
Problem Solving
1
1998
54
0.010
Why?
Receptors, Immunologic
1
1998
135
0.010
Why?
Acridine Orange
1
1996
2
0.010
Why?
Ethidium
1
1996
13
0.010
Why?
Electrophoresis, Agar Gel
1
1996
49
0.010
Why?
Histocytochemistry
1
1996
130
0.010
Why?
Cell Size
1
1996
69
0.010
Why?
Microscopy, Electron
1
1996
511
0.010
Why?
HIV Seronegativity
1
1995
13
0.010
Why?
Microscopy, Fluorescence
1
1996
428
0.010
Why?
Substance Abuse, Intravenous
1
1995
59
0.010
Why?
Adenosine Kinase
1
1994
1
0.010
Why?
Tubercidin
1
1994
1
0.010
Why?
Blood Physiological Phenomena
1
1994
9
0.010
Why?
Purinergic P1 Receptor Antagonists
1
1994
6
0.010
Why?
Scintillation Counting
1
1994
5
0.010
Why?
Flow Cytometry
1
1996
691
0.010
Why?
Dipyridamole
1
1994
14
0.010
Why?
Coronary Thrombosis
1
1994
14
0.010
Why?
Theophylline
1
1994
33
0.010
Why?
Plasma
1
1994
51
0.010
Why?
Adenosine Deaminase
1
1994
20
0.010
Why?
Cell Survival
1
1996
983
0.010
Why?
Regional Blood Flow
1
1994
198
0.010
Why?
Psychometrics
1
1995
330
0.010
Why?
Erythrocytes
1
1994
254
0.010
Why?
Aspirin
1
1994
159
0.010
Why?
Coronary Vessels
1
1994
190
0.010
Why?
Tumor Cells, Cultured
1
1994
1057
0.010
Why?
Glioblastoma
1
1994
265
0.010
Why?
Cohort Studies
1
1998
2872
0.010
Why?
Oxidative Stress
1
1994
458
0.010
Why?
DNA
1
1996
1308
0.010
Why?
Reproducibility of Results
1
1995
2758
0.010
Why?
Disease Models, Animal
1
1994
2366
0.000
Why?
Prostatic Neoplasms
1
1994
1769
0.000
Why?
Mullane's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (346)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_